论文部分内容阅读
目的研究分析少白细胞输血技术降低输血不良反应的临床效果。方法将100例需要进行输血治疗的患者随机分成2组作为研究对象(2014年4月20日至2017年4月20日收治),50例/组。对照组予以本组患者常规输血医治,实验组予以本组患者少白细胞输血医治,比较2组患者输血后出现的不良反应。结果实验组患者输血后不良反应发生概率较对照组更具优势(P<0.05)结论少白细胞输血技术可有效减少不良反应事件的出现,具有较高的临床应用价值。
Objective To study the clinical effect of reducing leukocyte transfusion in reducing adverse reactions of transfusion. Methods A total of 100 patients who needed blood transfusion were randomly divided into two groups (from April 20, 2014 to April 20, 2017), 50 cases / group. The control group was given routine blood transfusion in this group, and the experimental group was treated with leukocyte-less blood transfusion in this group. The adverse reactions after transfusion in the two groups were compared. Results The incidence of adverse reactions in the experimental group was more superior to that in the control group (P <0.05). Conclusion Leukocyte-less blood transfusion can effectively reduce the occurrence of adverse reactions and has high clinical value.